879 related articles for article (PubMed ID: 2416769)
61. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
[TBL] [Abstract][Full Text] [Related]
62. Receptor cross-talk can optimize assays for autoantibodies to the thyrotropin receptor: effect of phenylisopropyladenosine on adenosine 3',5'-monophosphate and inositol phosphate levels in rat FRTL-5 thyroid cells.
Hidaka A; Okajima F; Ban T; Kosugi S; Kondo Y; Kohn LD
J Clin Endocrinol Metab; 1993 Nov; 77(5):1164-9. PubMed ID: 8077307
[TBL] [Abstract][Full Text] [Related]
63. Characteristics of an scFv antibody fragment that binds to immunoglobulin G of Graves' disease patients and inhibits autoantibody-mediated thyroid-stimulating activity.
Zhao Y; Wang SL; Li Q; Ye J; Chen KM; Tian EJ; Chen ZP
Hybridoma (Larchmt); 2008 Dec; 27(6):445-51. PubMed ID: 19108617
[TBL] [Abstract][Full Text] [Related]
64. Thyrotropin receptor autoantibodies recognizing two different epitopes on the TSH receptor: lack of relationship to patient age, sex, and ophthalmopathy.
Jaume JC; Prummel MF; Wiersinga WM; McLachlan SM; Rapoport B
Thyroid; 1993; 3(4):291-5. PubMed ID: 7509670
[TBL] [Abstract][Full Text] [Related]
65. [Thyroid-stimulating immunoglobulins. The related antigens].
Pinchera A; Fenzi GF; Macchia E; Vitti P; Monzani F; Kohn LD
Ann Endocrinol (Paris); 1982 Dec; 43(6):520-33. PubMed ID: 6134493
[TBL] [Abstract][Full Text] [Related]
66. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.
Morris JC; Hay ID; Nelson RE; Jiang NS
Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572
[TBL] [Abstract][Full Text] [Related]
67. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients.
Osuga Y; Liang SG; Dallas JS; Wang C; Hsueh AJ
Endocrinology; 1998 Feb; 139(2):671-6. PubMed ID: 9449640
[TBL] [Abstract][Full Text] [Related]
68. [Thyroid stimulators other than TSH. Classification. Immunoglobulins of Basedow's disease: history, methodology, nomenclature].
Orgiazzi J; Madec AM
Ann Endocrinol (Paris); 1982 Dec; 43(6):509-19. PubMed ID: 6134492
[TBL] [Abstract][Full Text] [Related]
69. Heterogeneity of the Graves' immunoglobulins directed toward the thyrotropin receptor-adenylate cyclase system.
Carayon P; Adler G; Roulier R; Lissitzky S
J Clin Endocrinol Metab; 1983 Jun; 56(6):1202-8. PubMed ID: 6302125
[TBL] [Abstract][Full Text] [Related]
70. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
Hill BL; Erlanger BF
Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
[TBL] [Abstract][Full Text] [Related]
71. Clinical significance of classification of Graves' disease according to the characteristics of TSH receptor antibodies.
Kim WB; Chung HK; Park YJ; Park DJ; Lee HK; Cho BY
Korean J Intern Med; 2001 Sep; 16(3):187-200. PubMed ID: 11769578
[TBL] [Abstract][Full Text] [Related]
72. Graves' Autoantibodies Exhibit Different Stimulating Activities in Cultures of Thyrocytes and Orbital Fibroblasts Not Reflected by Clinical Assays.
Krieger CC; Kahaly GJ; Azam A; Klubo-Gwiezdzinska J; Neumann S; Gershengorn MC
Thyroid; 2022 Jan; 32(1):90-96. PubMed ID: 34714162
[No Abstract] [Full Text] [Related]
73. Regulation of intercellular adhesion molecule-1 expression in human thyroid cells in vitro and human thyroid tissue transplanted to the nude mouse in vivo: role of Graves' immunoglobulins and human thyrotropin receptor.
Hoermann R; Spitzweg C; Poertl S; Mann K; Heufelder AE; Schumm-Draeger PM
J Clin Endocrinol Metab; 1997 Jul; 82(7):2048-55. PubMed ID: 9215271
[TBL] [Abstract][Full Text] [Related]
74. [The effects of TSH, cholera toxin and Graves' IgG on cAMP production in cultured human thyroid adenoma cells in monolayer].
Tsuboi K
Nihon Naibunpi Gakkai Zasshi; 1985 May; 61(5):541-53. PubMed ID: 2862066
[TBL] [Abstract][Full Text] [Related]
75. The species specificity of TSH receptor binding antibodies as measured by radioreceptor study.
Strakosch CR; Joyner D; Manley SW; Wall JR
Clin Endocrinol (Oxf); 1982 Aug; 17(2):173-9. PubMed ID: 6127179
[TBL] [Abstract][Full Text] [Related]
76. Monoclonal antibodies to the thyrotropin receptor: the identification of blocking and stimulating antibodies.
Valente WA; Yavin Z; Yavin E; Grollman EF; Schneider M; Rotella CM; Zonefrati R; Toccafondi RS; Kohn LD
J Endocrinol Invest; 1982; 5(5):293-301. PubMed ID: 6296219
[TBL] [Abstract][Full Text] [Related]
77. Improvement of infiltrative ophthalmopathy in parallel with decrease of thyroid-stimulating antibody (TSAb) activity in two patients with hypothyroid Graves' disease.
Tamaki H; Amino N; Iwatani Y; Miyai K
J Endocrinol Invest; 1989 Jan; 12(1):47-53. PubMed ID: 2568374
[TBL] [Abstract][Full Text] [Related]
78. Thyrotrophin receptor blocking antibodies: incidence, characterization and in-vitro synthesis.
Kraiem Z; Lahat N; Glaser B; Baron E; Sadeh O; Sheinfeld M
Clin Endocrinol (Oxf); 1987 Oct; 27(4):409-21. PubMed ID: 2830061
[TBL] [Abstract][Full Text] [Related]
79. Membrane-binding antibodies in patients with Graves' disease and other autoimmune diseases.
Tao TW; Kriss JP
J Clin Endocrinol Metab; 1982 Nov; 55(5):935-40. PubMed ID: 6126489
[TBL] [Abstract][Full Text] [Related]
80. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
Khoo DH; Eng PH; Ho SC; Tai ES; Morgenthaler NG; Seah LL; Fong KS; Chee SP; Choo CT; Aw SE
Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
